The proportion of cells that expressed α-SMA and TGFBi in the two different control samples and two RDEB patients were assessed in 10 different fields, and a significant increase in α-SMA and TGFBi was evident in the fibroblasts from RDEB patients, reflecting the distinct ECM response of these cells. Here, TGFBI is linked to recessive dystrophic epidermolysis bullosa.